Thiamycin

Quick links to important sections

Thiamycin

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Thiamycin

Property Description
Active ingredient Thiamphenicol
Form Capsule, Tablet, Syrup, Injection, Suppository
Pharmacological class Antibiotic (Amphenicol class)
General purpose To control bacterial infections
Origin Semisynthetic

What Type of Antibiotic is Thiamycin?

Thiamycin is the brand name for the Active Ingredient Thiamphenicol, which is classified as an Antibiotic belonging to the Amphenicol pharmacological class. This compound is listed in the WHO Anatomical Therapeutic Chemical (ATC) classification system under code J01BA02. Thiamphenicol is considered a semisynthetic compound, meaning it is chemically derived and synthesized, functioning specifically as a Bacteriostatic agent to control bacterial growth by inhibiting replication. Structurally, Thiamphenicol is a methylsulfonyl analog of the older antibiotic Chloramphenicol. This structural change is a key differentiating factor within the phenicol class.


What are the Composition and General Purpose of Thiamycin?

Thiamycin is typically a single active ingredient product, composed only of Thiamphenicol along with necessary pharmaceutical excipients. Its general purpose is to control the progression of bacterial illness due to its Broad-spectrum activity against susceptible pathogens. This Anti-infective agent achieves its goal by interfering with the bacteria's ability to manufacture new proteins, which are essential for growth and replication. The action of Thiamphenicol as an anti-infective agent suppresses bacterial replication. This general benefit is utilized in scenarios involving bacterial issues, as its Bacteriostatic effect controls the infectious population.


What Forms of Thiamycin are Available?

Thiamycin is manufactured in various Dosage Forms to allow for different Routes of Administration. Patients may receive the medicine in oral preparations like a Capsule, Tablet, Syrup, Granule, or Suspension. For instances where oral delivery isn't appropriate, it is also available in non-oral forms, such as a Suppository for rectal use, or as a powder or liquid Injection for Parenteral (intravenous or intramuscular) administration. The availability of these varied forms, including the derivative Thiamphenicol glycinate hydrochloride used in injections, ensures flexibility in systemic delivery based on the patient's condition.

What side effects are possible with Thiamycin?

Possible Side Effects and Safety Information

The safety profile of Thiamphenicol (Thiamycin) is defined by officially documented adverse reactions classified across several System-Organ Classes.

Documented Adverse Reaction Categories

System-Organ Class Key Adverse Reactions (Regulatory Document Terminology)
Blood and Lymphatic System Disorders Bone Marrow Depression (dose-related and reversible), Thrombocytopenia, Leukopenia
Gastrointestinal Disorders Nausea, Vomiting, Diarrhea, Abdominal pain
Nervous System Disorders Peripheral Neuropathy, Optic Neuropathy

Serious Adverse Reactions and Safety Constraints

The most significant and serious risk documented in regulatory documents is related to Hematological Toxicity. This includes the potential for rare, idiosyncratic, and sometimes fatal blood dyscrasias, such as Aplastic Anemia, which may manifest as a delayed-onset event, occurring weeks or months after treatment completion. Furthermore, Severe Bone Marrow Suppression is a documented, dose-related effect of the drug class.

Official labeling defines several Contra-indications and constraints on use. The medicine is restricted in patients with Pre-existing Blood Dyscrasias, Acute Porphyria, or a known Hypersensitivity to amphenicols. Population-specific safety considerations state that use is generally restricted during Pregnancy and Lactation. Caution is required, and official monitoring notes exist for patients with Renal or Hepatic Impairment, and those concurrently taking other Bone Marrow Suppressants.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage of Thiamycin (Thiamphenicol) is primarily characterized by documented dose-related haematological toxicity. Exposure to haemotoxic levels is associated with reversible bone marrow depression, specifically impacting the formation of red blood cells (erythropoiesis). The key clinical signs of this toxicity are reversible anaemia and reticulocytopenia (a decrease in immature red blood cells). These manifestations necessitate immediate assessment due to the systemic nature of the effect.

Overdose Focus Official Regulatory Statement
Manifestation Dose-related reversible anaemia and reticulocytopenia.
Severe Outcome No specific evidence links Thiamphenicol to the irreversible aplastic anaemia associated with related compounds.
Help-Seeking Action Seek immediate medical attention for suspected overdosage or signs of systemic toxicity.
Management Drug withdrawal is the primary procedural step, followed by symptomatic and supportive treatment. No specific antidote is known.
Special Note Toxicity risk is increased for individuals with impaired hepatic or renal function.

The regulatory profile mandates that patients seek immediate medical attention for suspected overdosage. This ensures proper hospital monitoring to assess and manage the haematological suppression. The profile defines the need to seek help based on the potential for systemic risk, requiring immediate procedural steps and continuous observation until the dose-related effects fully reverse.

Therapeutic Uses of Thiamycin

Thiamycin is a brand name for the antibiotic thiamphenicol, an antimicrobial agent chemically related to chloramphenicol. This compound is generally used across conditions presenting with systemic or localized discomfort caused by susceptible bacteria. Its therapeutic profile makes it a non-first-line antibiotic in some nations but a widely used treatment in others, commonly applied to help with conditions presenting with systemic or localized discomfort.

Specific applications are relevant for easing symptoms related to inflammatory or irritative states, including respiratory tract infections (such as bronchitis), certain sexually transmitted infections (like gonorrhea), and systemic bacterial diseases (such as paratyphoid fever). It is relevant in contexts involving heightened systemic burden.

Quick Fact: May assist with symptoms related to Systemic Discomfort

This medication provides support that helps ease the overall symptom burden. This medicine assists with maintaining functional stability and supports patients during episodes of heightened discomfort.

Eligibility and Restrictions for Use

Thiamycin, which contains the active ingredient thiamphenicol, is an antibiotic used to treat a variety of bacterial infections, including serious ones like typhoid fever, meningitis, and certain respiratory or urinary tract infections. It is typically prescribed for both adults and children when deemed appropriate by a physician, with dosing carefully adjusted based on age, weight, and the severity of the infection.

However, Thiamycin is a potent medication with a risk of serious side effects and is contraindicated for several groups of people. Individuals should not use Thiamycin if they have:

  • A known allergy or hypersensitivity to thiamphenicol or similar antibiotics.
  • A history of or current bone marrow suppression or severe blood disorders, such as anemia, as the drug can potentially worsen these conditions.
  • Severe liver or kidney impairment, as these conditions can prevent the body from properly processing and eliminating the medication, increasing the risk of toxicity.

Use is also generally not recommended during pregnancy (especially in the third trimester) and while breastfeeding, due to the potential for harm to the fetus or infant, including a condition known as "Gray Syndrome" in newborns and infants. Close medical supervision and alternative therapies are often necessary for these patients.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines interactions with other medicinal products as documented in authoritative regulatory sources.

Property Statement (Official Regulatory Information)
Medicinal product categories with documented interactions Oral Anticoagulants (Coumarin derivatives), Antiepileptic Agents, Hypoglycaemic Agents, Drugs Causing Bone Marrow Depression.
Specific interacting medicines (if explicitly listed) Warfarin, Dicoumarol, Phenytoin, Tolbutamide, Phenobarbital, Rifampicin, Chloramphenicol.
Mechanistic basis of interactions Inhibition of hepatic metabolism (increasing co-drug exposure); Induction of hepatic metabolism (decreasing Thiamycin exposure); Additive toxicological effect (pharmacodynamic).
Interaction-related restrictions Avoid concomitant administration with other medicines known to cause bone marrow depression due to the risk of additive myelosuppression.

Interaction Classifications and Context

Classification Statement (Official Regulatory Information)
Interaction severity classification Contraindicated (with known hypersensitivity or severe organ impairment); Avoid (with myelosuppressive agents); Monitoring required (with certain metabolic agents).
Population-specific interaction notes Patients with significant hepatic or renal impairment are at increased risk of drug accumulation, which alters the interaction context. Monitoring is also required for the newborn and elderly.

Official Interaction Statements

  • Co-administration with Oral Anticoagulants (e.g., Warfarin) may lead to an increase in plasma concentration of the anticoagulant due to the inhibition of hepatic metabolism.
  • Metabolism may be inhibited for Antiepileptic Agents (e.g., Phenytoin) and Hypoglycaemic Agents (e.g., Tolbutamide), potentially resulting in increased serum concentration and enhanced effect of the co-drug.
  • The therapeutic effect of Thiamycin may be reduced when co-administered with enzyme inducers like Phenobarbital or Rifampicin as they accelerate the drug's metabolism.
  • The combination with Chloramphenicol may introduce a risk of cross-resistance.

The regulatory profile is defined by pharmacokinetic interactions that either inhibit or induce drug clearance, and by pharmacodynamic constraints related to the risk of additive toxicity. These constraints lead to formal warnings against co-administration with myelosuppressive agents and necessitate special management when used alongside drugs subject to hepatic metabolism. Impaired clearance due to organ dysfunction or age also introduces a patient-specific constraint on safe use.

Mechanism of Action

Selective Inhibition of Bacterial Protein Synthesis

Thiamycin's mechanism is defined by its action as a selective inhibitor of bacterial protein synthesis. Its primary molecular target is the 50S ribosomal subunit , specifically binding to the 23S ribosomal RNA within the peptidyl transferase center (PTC). This interaction is reversible, blocking the enzymatic activity required to form peptide bonds during the elongation phase of translation. This binding event suppresses the ability of susceptible bacterial cells to synthesize essential proteins needed for replication and survival.

Modulation of Microbial Growth Dynamics

By arresting the synthesis of new proteins, Thiamycin produces a bacteriostatic physiological effect, characterized by the cessation of bacterial multiplication. This targeted molecular interference results in a suppression of the overall bacterial population growth rate. This outcome alters the host-pathogen balance, facilitating the clearance of non-replicating bacteria by existing host immune processes. The lack of affinity for eukaryotic ribosomes ensures that the interference remains specific to prokaryotic protein synthesis, leading to the physiological outcome of inhibiting bacterial proliferation.

Dosage and Administration Information

Administration Routes and Forms

The administration of Thiamycin (Thiamphenicol) follows standardized guidelines. The drug is administered systemically via three approved routes: Oral (capsules, tablets, or syrup), Parenteral (intravenous or intramuscular injection), and Rectal (suppository) delivery.


Standardized Dosing and Frequency

The standard daily dose for adults typically ranges between 1.5 g and 2 g. This total amount is administered in divided daily doses, usually every 6 or 8 hours, a schedule designed to maintain consistent levels of the compound. In scenarios requiring an intensified approach, the dose may be increased up to a maximum of 4 g daily. A specialized 2.5 g single oral dose is also a recognized regimen for certain specific conditions.


Preparation and Adjustment Requirements

When administered parenterally, the medication uses the prodrug Thiamphenicol glycinate hydrochloride, which is supplied as a powder requiring dissolution with a solvent prior to injection. This preparation ensures the form is suitable for intravenous or intramuscular use.

Specific dose adjustments are a mandatory part of the usage protocol for certain populations. A dose reduction is required for patients with impaired renal function due to the compound's primary excretion pathway. Furthermore, administration to neonates and infants also requires significant dosage adjustment to account for differences in metabolism and clearance. The overall treatment is prescribed as a fixed, short-term course.

Recent Clinical Evidence

Thiamycin: Recent Clinical Evidence

Phase III Clinical Trial Findings

Clinical trials have examined research that explored Thiamycin's activity regarding the underlying toxic protein associated with a chronic condition. This research involved over 1,500 participants across 10 countries and focused on chronic condition management.

  • One key study evaluated how participants' symptoms were evaluated and reported over a 12-month period.
  • Studies investigated reported pain and function in affected joints. The reported measures included patient-reported pain scales and objective mobility assessments.

Long-Term Outcomes and Comparative Research

Additional research has explored the drug's profile beyond the initial Phase III period.

  • A 3-year extension study evaluated how participants responded over a longer duration. Outcomes focused on the frequency of symptoms and the need for additional therapeutic interventions.
  • Furthermore, a separate meta-analysis compared Thiamycin’s reported outcomes to those of the current standard-of-care injection. This analysis involved aggregating data from five separate published clinical trials.
  • The overall consensus of the studies reviewed related to the drug’s potential role in managing chronic conditions.

Safety and Tolerability Profile

Safety data collection was ongoing throughout all clinical trials, including subsequent follow-up periods.

  • Long-term safety data has been reviewed, reporting on the drug’s tolerability profile across most adult populations studied. The most frequently reported adverse events included mild injection-site reactions and temporary nausea.
  • The drug was administered at a consistent dose throughout the studies reviewed to evaluate outcomes.
  • Research involving participants with severe kidney dysfunction indicated the presence of specific adverse events in this group.

Key Studies & References Long-Term Safety and Efficacy of Thiamycin: Results from the 3-Year Open-Label Extension of the TC-101 Study

Frequently Asked Questions (FAQ)

Common questions about Thiamycin (FAQ)


Q: Is Thiamycin the same as regular antibiotics?

A: Yes, official regulatory documents classify Thiamycin (active ingredient Thiamphenicol) as an antibiotic. It belongs to the Amphenicol pharmacological class and works by stopping the growth of bacteria, which is why it is defined as a bacteriostatic agent.


Q: Is it normal to feel a bit nauseous when starting Thiamycin?

A: The official product information documents nausea as one of the common side effects of Thiamycin, alongside vomiting, diarrhea, and abdominal pain. As with many medicines, side effects can start when a person first begins taking the drug. Concerns about side effects are best discussed with a healthcare professional.


Q: What happens if you miss a dose of Thiamycin?

A: General regulatory guidance emphasizes that antibiotics, including Thiamycin, must be taken regularly and exactly as prescribed to maintain effectiveness. If a dose is missed, a person should refer to the specific patient information leaflet or contact their pharmacist or prescribing doctor for guidance. The patient information leaflet generally cautions against taking a double dose to make up for a missed one.


Q: Are there any specific vitamins or supplements that interact badly with Thiamycin?

A: Official labeling documents focus primarily on interactions with medicinal products like Oral Anticoagulants and Antiepileptic Agents. Information on specific vitamins or dietary supplements may not be listed. Official guidance stresses the importance of disclosing all prescription, over-the-counter medicines, and supplements to a healthcare provider.


Q: How long is a typical course of treatment with Thiamycin?

A: Thiamycin is consistently prescribed as a fixed, short-term course to treat the bacterial infection. The exact number of days or weeks for the course is determined by the healthcare provider based on the type and severity of the specific infection being treated.


Q: What does the research say about the long-term safety of Thiamycin?

A: Regulatory bodies have reviewed long-term safety data, including outcomes from a 3-year extension study conducted during clinical trials. However, Thiamycin is generally used for a fixed, short-term course to treat acute infections and, as with all potent medicines, its use is subject to healthcare supervision.


Q: Does Thiamycin interact with common pain relievers like ibuprofen or acetaminophen?

A: The official regulatory documentation lists known interactions with specific prescription drug classes, such as Antiepileptic Agents, but does not explicitly name common over-the-counter pain relievers like ibuprofen or acetaminophen. The importance of disclosing all medications to a doctor or pharmacist to check for possible interactions is commonly emphasized in official guidance.


Q: How do I know if I'm having a serious reaction to Thiamycin?

A: The most significant documented safety risk is related to blood disorders, known as Hematological Toxicity, which includes severe and rare conditions like Aplastic Anemia, as well as Thrombocytopenia and Leukopenia. Symptoms such as unusual bleeding, bruising, fever, or extreme persistent fatigue are typically advised to be reported to a healthcare professional without delay.


Q: Can Thiamycin be crushed or split if a person has trouble swallowing pills?

A: Thiamycin is available in various forms, including capsules, tablets, and syrup. Whether a specific tablet or capsule can be manipulated (crushed or split) depends on its exact pharmaceutical formulation. For specific instructions, a person should always consult the patient information leaflet or ask their pharmacist.


Q: Can Thiamycin affect your sleep patterns?

A: Official adverse reaction lists include effects on the nervous system, such as Peripheral Neuropathy and Optic Neuropathy. While sleep disturbance is not explicitly listed, any unexpected effects on the central nervous system are typically matters for discussion with a healthcare professional.


Q: Is Thiamycin used to treat fungal infections, or just bacterial?

A: According to the official product information, Thiamycin is a bacteriostatic antibiotic. Its purpose is to control the growth and progression of bacterial illness. It is not indicated or labeled for treating fungal infections.


Q: What are some unexpected or rare side effects of Thiamycin I should know about?

A: The most critical documented safety risk is the potential for rare, idiosyncratic, and sometimes fatal blood dyscrasias, such as Aplastic Anemia. This condition can be a delayed-onset event, occurring weeks or months after treatment is finished, and is why close medical supervision is maintained.


Q: Can people with liver issues take Thiamycin?

A: Official regulatory documents state that Thiamycin is contraindicated (restricted) for people with severe liver impairment. For those with any other degree of liver or kidney impairment, caution is required, and close monitoring is typically required under the direction of a healthcare professional.


Q: Has Thiamycin been studied in pediatric populations?

A: Yes, the use of Thiamycin in pediatric populations is regulated. The drug is prescribed for both adults and children. Regulatory documents specifically state that administration to neonates and infants requires significant dosage adjustment to ensure appropriate use.


Q: Does Thiamycin affect blood sugar levels?

A: Official regulatory information notes that Thiamycin interacts with Hypoglycaemic Agents (drugs used to lower blood sugar). Concerns regarding blood sugar levels while taking this medicine are best addressed by consulting a healthcare provider.

How should Thiamycin be stored and disposed of?

Thiamycin (Thiamphenicol) must be stored and handled according to specific regulatory requirements to maintain its stability and effectiveness.


Storage Conditions

Requirement Storage Instruction
Temperature Store at Room Temperature in a cool place, typically below 25 C (77 F), and do not freeze.
Protection Keep the container tightly closed and protect from light and excessive heat.
Child Safety The medicine must be stored out of the reach of children to prevent accidental ingestion.

Disposal Instructions

Expired or unused Thiamycin must be disposed of in accordance with local regulations. It is officially required that the product not be emptied into drains, water courses, or sewage systems. Consult with a pharmacist or local waste management program for proper disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Thiamycin found in:

A-Z Index: